Global Chronic Myelogenous Leukemia Therapeutics Market 2022-2026

Global Chronic Myelogenous Leukemia Therapeutics Market 2022-2026

Technavio has been monitoring the chronic myelogenous leukemia therapeutics market and it is poised to grow by $ 2.14 bn during 2022-2026, accelerating at a CAGR of 6.1% during the forecast period. Our report on the chronic myelogenous leukemia therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by strategic alliances.

The chronic myelogenous leukemia therapeutics market analysis includes the product segment and geographic landscape.

Technavio's chronic myelogenous leukemia therapeutics market is segmented as below:

By Product

  • Targeted therapy
  • Chemotherapy
  • Immunotherapy
By Geographical Landscape
  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the emergence of pipeline molecules as one of the prime reasons driving the chronic myelogenous leukemia therapeutics market growth during the next few years. Also, the development of diagnostic tests and predictive markers and increasing research in regenerative medicines will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the chronic myelogenous leukemia therapeutics market covers the following areas:
  • Chronic myelogenous leukemia therapeutics market sizing
  • Chronic myelogenous leukemia therapeutics market forecast
  • Chronic myelogenous leukemia therapeutics market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading chronic myelogenous leukemia therapeutics market vendors that include Amneal Pharmaceuticals Inc., Bristol Myers Squibb Co., C. H. Boehringer Sohn AG and Co. KG, Dr Reddys Laboratories Ltd, F. Hoffmann La Roche Ltd., Ilyang Pharmaceutical Co. Ltd., Innovent Biologics Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sheba Medical Center, Sun Pharmaceutical Industries Ltd, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., Lupin Ltd, and Otsuka Holdings Co Ltd. Also, the chronic myelogenous leukemia therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.


  • Executive Summary
    • Market overview
      • Table Executive Summary - Chart on Market Overview
      • Table Executive Summary - Data Table on Market Overview
      • Table Executive Summary - Chart on Global Market Characteristics
      • Table Executive Summary - Chart on Market by Geography
      • Table Executive Summary - Chart on Market Segmentation by Product
      • Table Executive Summary - Chart on Incremental Growth
      • Table Executive Summary - Data Table on Incremental Growth
      • Table Executive Summary - Chart on Vendor Market Positioning
  • Market Landscape
    • Market ecosystem
      • Table Parent market
      • Table Market Characteristics
  • Market Sizing
    • Market definition
      • Table Offerings of vendors included in the market definition
    • Market segment analysis
      • Table Market segments
    • Market size 2021
    • Market outlook: Forecast for 2021-2026
      • Table Chart on Global - Market size and forecast 2021-2026 ($ million)
      • Table Data Table on Global - Market size and forecast 2021-2026 ($ million)
      • Table Chart on Global Market: Year-over-year growth 2021-2026 (%)
      • Table Data Table on Global Market: Year-over-year growth 2021-2026 (%)
  • Five Forces Analysis
    • Five forces summary
      • Table Five forces analysis - Comparison between 2021 and 2026
    • Bargaining power of buyers
      • Table Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers - Impact of key factors in 2021 and 2026
    • Threat of new entrants
      • Table Threat of new entrants - Impact of key factors in 2021 and 2026
    • Threat of substitutes
      • Table Threat of substitutes - Impact of key factors in 2021 and 2026
    • Threat of rivalry
      • Table Threat of rivalry - Impact of key factors in 2021 and 2026
    • Market condition
      • Table Chart on Market condition - Five forces 2021 and 2026
  • Market Segmentation by Product
    • Market segments
      • Table Chart on Product - Market share 2021-2026 (%)
      • Table Data Table on Product - Market share 2021-2026 (%)
    • Comparison by Product
      • Table Chart on Comparison by Product
      • Table Data Table on Comparison by Product
    • Targeted therapy - Market size and forecast 2021-2026
      • Table Chart on Targeted therapy - Market size and forecast 2021-2026 ($ million)
      • Table Data Table on Targeted therapy - Market size and forecast 2021-2026 ($ million)
      • Table Chart on Targeted therapy - Year-over-year growth 2021-2026 (%)
      • Table Data Table on Targeted therapy - Year-over-year growth 2021-2026 (%)
    • Chemotherapy - Market size and forecast 2021-2026
      • Table Chart on Chemotherapy - Market size and forecast 2021-2026 ($ million)
      • Table Data Table on Chemotherapy - Market size and forecast 2021-2026 ($ million)
      • Table Chart on Chemotherapy - Year-over-year growth 2021-2026 (%)
      • Table Data Table on Chemotherapy - Year-over-year growth 2021-2026 (%)
    • Immunotherapy - Market size and forecast 2021-2026
      • Table Chart on Immunotherapy - Market size and forecast 2021-2026 ($ million)
      • Table Data Table on Immunotherapy - Market size and forecast 2021-2026 ($ million)
      • Table Chart on Immunotherapy - Year-over-year growth 2021-2026 (%)
      • Table Data Table on Immunotherapy - Year-over-year growth 2021-2026 (%)
    • Market opportunity by Product
      • Table Market opportunity by Product ($ million)
  • Customer Landscape
    • Customer landscape overview
      • Table Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Geographic Landscape
    • Geographic segmentation
      • Table Chart on Market share by geography 2021-2026 (%)
      • Table Data Table on Market share by geography 2021-2026 (%)
    • Geographic comparison
      • Table Chart on Geographic comparison
      • Table Data Table on Geographic comparison
    • North America - Market size and forecast 2021-2026
      • Table Chart on North America - Market size and forecast 2021-2026 ($ million)
      • Table Data Table on North America - Market size and forecast 2021-2026 ($ million)
      • Table Chart on North America - Year-over-year growth 2021-2026 (%)
      • Table Data Table on North America - Year-over-year growth 2021-2026 (%)
    • Europe - Market size and forecast 2021-2026
      • Table Chart on Europe - Market size and forecast 2021-2026 ($ million)
      • Table Data Table on Europe - Market size and forecast 2021-2026 ($ million)
      • Table Chart on Europe - Year-over-year growth 2021-2026 (%)
      • Table Data Table on Europe - Year-over-year growth 2021-2026 (%)
    • Asia - Market size and forecast 2021-2026
      • Table Chart on Asia - Market size and forecast 2021-2026 ($ million)
      • Table Data Table on Asia - Market size and forecast 2021-2026 ($ million)
      • Table Chart on Asia - Year-over-year growth 2021-2026 (%)
      • Table Data Table on Asia - Year-over-year growth 2021-2026 (%)
    • Rest of World (ROW) - Market size and forecast 2021- 2026
      • Table Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Table Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Table Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
      • Table Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
    • US - Market size and forecast 2021-2026
      • Table Chart on US - Market size and forecast 2021-2026 ($ million)
      • Table Data Table on US - Market size and forecast 2021-2026 ($ million)
      • Table Chart on US - Year-over-year growth 2021-2026 (%)
      • Table Data Table on US - Year-over-year growth 2021-2026 (%)
    • Germany - Market size and forecast 2021-2026
      • Table Chart on Germany - Market size and forecast 2021-2026 ($ million)
      • Table Data Table on Germany - Market size and forecast 2021-2026 ($ million)
      • Table Chart on Germany - Year-over-year growth 2021-2026 (%)
      • Table Data Table on Germany - Year-over-year growth 2021-2026 (%)
    • UK - Market size and forecast 2021-2026
      • Table Chart on UK - Market size and forecast 2021-2026 ($ million)
      • Table Data Table on UK - Market size and forecast 2021-2026 ($ million)
      • Table Chart on UK - Year-over-year growth 2021-2026 (%)
      • Table Data Table on UK - Year-over-year growth 2021-2026 (%)
    • China - Market size and forecast 2021-2026
      • Table Chart on China - Market size and forecast 2021-2026 ($ million)
      • Table Data Table on China - Market size and forecast 2021-2026 ($ million)
      • Table Chart on China - Year-over-year growth 2021-2026 (%)
      • Table Data Table on China - Year-over-year growth 2021-2026 (%)
    • Canada - Market size and forecast 2021-2026
      • Table Chart on Canada - Market size and forecast 2021-2026 ($ million)
      • Table Data Table on Canada - Market size and forecast 2021-2026 ($ million)
      • Table Chart on Canada - Year-over-year growth 2021-2026 (%)
      • Table Data Table on Canada - Year-over-year growth 2021-2026 (%)
    • Market opportunity by geography
      • Table Market opportunity by geography ($ million)
  • Drivers, Challenges, and Trends
    • Market drivers
      • Advent of novel therapies
      • Patient assistance programs for TKIs
      • Strategic alliances
    • Market challenges
      • Patent expiration of TKIs
      • Availability of substitutes
      • Late diagnosis of CML
    • Impact of drivers and challenges
      • Table Impact of drivers and challenges in 2021 and 2026
    • Market trends
      • Emergence of pipeline molecules
      • Development of diagnostic tests and predictive markers
      • Increasing research in regenerative medicines
  • Vendor Landscape
    • Overview
    • Vendor landscape
      • Table Overview on Criticality of inputs and Factors of differentiation
    • Landscape disruption
      • Table Overview on factors of disruption
    • Industry risks
      • Table Impact of key risks on business
  • Vendor Analysis
    • Vendors covered
      • Table Vendors covered
    • Market positioning of vendors
      • Table Matrix on vendor position and classification
    • Bristol Myers Squibb Co.
      • Table Bristol Myers Squibb Co. - Overview
      • Table Bristol Myers Squibb Co. - Product / Service
      • Table Bristol Myers Squibb Co. - Key offerings
    • C. H. Boehringer Sohn AG and Co. KG
      • Table C. H. Boehringer Sohn AG and Co. KG - Overview
      • Table C. H. Boehringer Sohn AG and Co. KG - Business segments
      • Table C. H. Boehringer Sohn AG and Co. KG - Key news
      • Table C. H. Boehringer Sohn AG and Co. KG - Key offerings
      • Table C. H. Boehringer Sohn AG and Co. KG - Segment focus
    • Merck KGaA
      • Table Merck KGaA - Overview
      • Table Merck KGaA - Business segments
      • Table Merck KGaA - Key news
      • Table Merck KGaA - Key offerings
      • Table Merck KGaA - Segment focus
    • Novartis AG
      • Table Novartis AG - Overview
      • Table Novartis AG - Business segments
      • Table Novartis AG - Key offerings
      • Table Novartis AG - Segment focus
    • Otsuka Holdings Co Ltd
      • Table Otsuka Holdings Co Ltd - Overview
      • Table Otsuka Holdings Co Ltd - Business segments
      • Table Otsuka Holdings Co Ltd - Key offerings
      • Table Otsuka Holdings Co Ltd - Segment focus
    • Pfizer Inc.
      • Table Pfizer Inc. - Overview
      • Table Pfizer Inc. - Product / Service
      • Table Pfizer Inc. - Key news
      • Table Pfizer Inc. - Key offerings
    • Sun Pharmaceutical Industries Ltd
      • Table Sun Pharmaceutical Industries Ltd - Overview
      • Table Sun Pharmaceutical Industries Ltd - Product / Service
      • Table Sun Pharmaceutical Industries Ltd - Key offerings
    • Takeda Pharmaceutical Co. Ltd.
      • Table Takeda Pharmaceutical Co. Ltd. - Overview
      • Table Takeda Pharmaceutical Co. Ltd. - Product / Service
      • Table Takeda Pharmaceutical Co. Ltd. - Key news
      • Table Takeda Pharmaceutical Co. Ltd. - Key offerings
    • Teva Pharmaceutical Industries Ltd.
      • Table Teva Pharmaceutical Industries Ltd. - Overview
      • Table Teva Pharmaceutical Industries Ltd. - Business segments
      • Table Teva Pharmaceutical Industries Ltd. - Key news
      • Table Teva Pharmaceutical Industries Ltd. - Key offerings
      • Table Teva Pharmaceutical Industries Ltd. - Segment focus
    • Viatris Inc.
      • Table Viatris Inc. - Overview
      • Table Viatris Inc. - Business segments
      • Table Viatris Inc. - Key offerings
      • Table Viatris Inc. - Segment focus
  • Appendix
    • Scope of the report
      • Market definition
      • Objectives
      • Notes and caveats
    • Inclusions and exclusions checklist
      • Table Inclusions checklist
      • Table Exclusions checklist
    • Currency conversion rates for US$
      • Table Currency conversion rates for US$
    • Research methodology
      • Table Research methodology
      • Table Validation techniques employed for market sizing
      • Table Information sources
    • List of abbreviations
      • Table List of abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings